The effects of nucleotides and nucleosides on steroidogenesis and aerobic lactic-acid production were examined in unsectioned mouse adrenal glands preincubated for 1 h and then incubated for 2 h in Krebs\p=n-\Ringer 18,20-cyclo-20,21-dihydroxypregn-4-en-3-one, added by itself stimulated lactic-acid production. Added in combination with other steroids, it specifically counteracted the inhibitory effect of 18-OH-DOC, a steroid of potentially adverse biological properties. Our results are compatible with the concept that adrenal aerobic glycolysis is to a significant extent, but not exclusively, steroid-mediated. The glycolytically active but steroidogenically inert nucleotides and nucleosides offer examples of a dissociation between the two events.
production. Cyclic AMP caused a three-to fivefold stimulation, cyclic GMP an increase of only 20\p=n-\30%, and GMP, AMP and ADP increases of 80\p=n-\100%. Cyclic GMP, protected from hydrolysis, may thus inhibit lactic-acid as well as steroid production in the mouse adrenal gland. By contrast, cyclic GMP was nearly as effective as cyclic AMP in stimulating glycolysis and steroidogenesis of rat adrenal glands. The proportion of corticosterone to 18\ x=r eq-\ hydroxydeoxycorticosterone (18-OH-DOC) obtained with cyclic GMP was, however, always lower than that obtained with cyclic AMP. Cyclic AMP, as opposed to cyclic GMP, increased the formation of corticosterone and lactic acid in the presence of exogenous deoxycorticosterone (DOC) beyond that expected from an additive response. Lactic-acid production was inhibited by 18-OH-DOC, a major secretory product of the rat but not the mouse adrenal. This steroid, furthermore, greatly reduced the stimulation of glycolysis evoked by added DOC, 11\g=b\-hydroxyprogesterone and corticosterone, facts that could account for the greater glycolytic activity of mouse compared with rat adrenals. The yield of corticosterone in the presence of added 11\g=b\-hydroxyprogesterone, but not of DOC, was also reduced by 18-OH-DOC, denoting a selective inhibition of 21-hydroxylation. A structural analogue of 18-OH-DOC, 18,20-cyclo-20,21-dihydroxypregn-4-en-3-one, added by itself stimulated lactic-acid production. Added in combination with other steroids, it specifically counteracted the inhibitory effect of 18-OH-DOC, a steroid of potentially adverse biological properties. Our results are compatible with the concept that adrenal aerobic glycolysis is to a significant extent, but not exclusively, steroid-mediated. The glycolytically active but steroidogenically inert nucleotides and nucleosides offer examples of a dissociation between the two events. INTRODUCTION That adrenocorticotrophin (ACTH) stimulates not only steroidogenesis, but also aerobic lactic-acid production, was first established with the use of intact mouse adrenal glands in vitro (Birmingham, Huberman & Riven, 1969) . In contrast with the steroidogenic response, the glycolytic response of the mouse adrenal to ACTH requires the presence of exogenous glucose, and the increment of lactic-acid formation is stoichiometrically accounted for by the disappearance of glucose from the medium . The production of lactic acid in this preparation is also stimulated in a dose-dependent manner by cyclic AMP and its dibutyryl derivative, and by corticosterone, 11-deoxycorticosterone (DOC), 11 ß-hydroxyprogesterone and progesterone, provided the steroids are added in sufficiently high concentrations to induce a rise in the adrenal tissue content of corticosterone comparable to that evoked by ACTH (Bartova, Tibagong & Birmingham, 1971) . The glycolytic effects of ACTH and cyclic AMP may therefore be to a significant extent steroidmediated. In the present work, the response by mouse and rat adrenal glands to a variety of nucleotides, nucleosides and steroids has been examined in order to obtain more information on their role in controlling adrenal glycolysis and steroidogenesis, and the extent to which these two phenomena might be causally related.
MATERIALS AND METHODS
The experiments were performed on adrenal glands from 22-day-old Swiss final concentration of 0-45% in experimental and control media in the experiments involving exogenous steroids. At the end of the incubation, the steroids were extracted with dichloromethane from the medium and in some experiments from the glands homogenized in 0-9% (w/v) NaCl solution and dried. Corticosterone was measured by fluorometry (Zenker & Bernstein, 1958), 18-hydroxydeoxycorticosterone (18-OH-DOC) by the Porter-Silber reaction (Silber & Porter, 1954; Birmingham & Ward, 1961) , and lactic acid in the medium by the method of Barker & Summerson ( 1941 1 pM-ACTH. By contrast, cyclic GMP caused a consistent and statistically highly significant inhibition of corticosterone production ranging from 40 to 55%. The non-cyclic nucleotides were ineffective or caused slight inhibition, the nucleosides were without effect. Corticosterone production in the presence of the combined addition of cyclic AMP and cyclic GMP did not differ significantly from an additive response.
Lactic-acid production Statistically significant increases in lactic-acid production by mouse adrenal glands were obtained with all nucleotides and nucleosides tested, except ATP, but they were most pronounced with cyclic AMP, which evoked a three-to fivefold increase over the unstimulated output. Cyclic GMP increased lactic-acid production by only 20-30%, in contrast with the corresponding non-cyclic nucleotide GMP, a potential conversion product, which doubled glycolysis, as did AMP and ADP. An increase of 40% was evoked by IMP. Lactic-acid production in the presence of both cyclic AMP and cyclic GMP was significantly below that expected from an additive response.
Effects of cyclic AMP and cyclic GMP on rat adrenal glands
Steroid production
In striking contrast to the opposing responses to cyclic AMP and cyclic GMP noted with mouse adrenal glands, both cyclic nucleotides stimulated steroidogenesis in rat adrenal glands (Fig. 2) 2-5 ±01 3-7±0-2*** 71-6 + 2-2*** 86-0 + 2-0*** 13-2 + 2-9tt 51 ±0-6 24-1 ±2-8** 38-2 ±2-3*** 68-7 ±2-6*** ll-5±4-5t 12-4+1-6*** 18-7±2-8*** 18-6±0-8*** -10-4±3-ltt *P<00S; **/><001; ***/><0001: compared with value in row a. tDeviation from an additive response significant at F<005; tt deviation from an additive response significant at < 001. Degrees of freedom: expt 1,1 and 12; expts 2 and 3, 1 and 8. The s.e. for the difference between the sums of two means is shown.
Effects of combinations of steroids on adrenal lactic-acid production Natural steroids
The weaker glycolytic response of rat compared with mouse adrenals to cyclic AMP and, as noted in earlier work , to ACTH suggested species-dependent differences in the steroid-mediated component of glycolysis, as rat but not mouse adrenals secrete 18-OH-DOC. Previous investigations had indicated that 18-OH-DOC does not stimulate glycolysis ). The possibility that it might inhibit the glycolysis evoked by corticosterone and precursors to corticosterone was tested in experiments summarized in Fig. 3b . Added by itself, 18-OH-DOC slightly reduced lactic-acid production in mouse adrenals, by 12-21 pg/100 mg. In combination with DOC, 11 ß-hydroxy¬ progesterone or corticosterone, the inhibitory effect of 18-OH-DOC was much more pronounced, averaging reductions of 52, 86 and 70 pg/100 mg respectively. The conversion of 11 ß-hydroxyprogesterone, but not of DOC, to corticosterone was greatly decreased by 18-OH-DOC, suggesting a specific inhibition of 21-hydroxylation (Fig. 3c ). Since earlier experiments had indicated that the glycolytic response to steroids depended upon an increase in the corticosterone content of the tissue , the corticosterone content in the glands was measured as well. The inhibitory effect of 18-OH-DOC on lacticacid production was accompanied by a significant reduction of tissue corticosterone only in the glands exposed to the combination of 18-OH-DOC and 11 ß-hydroxyprogesterone. 4-en-3-one, has the same stereochemical configuration as 18-OH-DOC but the epoxylinkage between carbons 18 and 20 is replaced by a carbon-carbon bond (Li, Birmingham & Chan, 1976) . In contrast to 18-OH-DOC, the 18,20-cyclo-analogue stimulated lactic-acid production, and was thus an example of a glycolytically active steroid not convertible to corticosterone (Fig. 3a) . . Corticosterone production was reduced by half in mouse adrenals and stimulated tenfold in rat adrenals exposed to cyclic GMP. The Yin-Yang hypothesis of opposing functions for these nucleotides (Goldberg, 1975) may thus apply to the mouse but not the rat, its closest phylogenetic neighbour. Although lactic-acid production in mouse adrenals was increased slightly by cyclic GMP, the potential conversion product, GMP, was four times as active. Cyclic GMP greatly reduced the yield of lactic acid, but not ofcorticosterone, obtained in the presence of cyclic AMP suggesting interference with a component of glycolysis not mediated by steroids.
The finding that glycolysis in the rat adrenal is not as effectively stimulated by cyclic AMP and ACTH as is that in the mouse adrenal agrees with the concept that adrenal glycolysis is to a significant extent steroid-mediated since it may be accounted for by our observation that 18-OH-DOC, a major secretory product of the rat, but not the mouse, inhibits adrenal lacticacid production and reduces the stimulation induced by the addition of corticosterone and potential precursors to corticosterone.
Nucleotide effects on steroid metabolism The higher proportion of corticosterone to 18-OH-DOC obtained with cyclic AMP suggested differential effects of the cyclic nucleotides on late stages of steroid synthesis. Evidence for a differential effect on 11-hydroxylation was indeed obtained in experiments utilizing exogenous DOC which was converted more efficiently to corticosterone in the presence of cyclic AMP, but not of cyclic GMP. The yield of 18-OH-DOC from the combined addition of DOC with either cyclic GMP or cyclic AMP was less than additive. With DOC plus cyclic GMP the deficit was highly significant and corresponded exactly to the nucleotide-induced formation of 18-OH-DOC from endogenous sources. Exogenous DOC thus appeared to inhibit the conversion of endogenous substrate to 18-OH-DOC, but not to corticosterone. This is difficult to envisage if both end-products are derived from a common endogenous immediate precursor in the same cytological location. Our findings are compatible with a compartmentalization of precursor pools as suggested by and (Heap, Holzbauer & Newport, 1966; Traikov & Birmingham, 1966; Holzbauer & Newport, 1969) , and to be a more efficient exogenous precursor to corticosterone than is DOC (Kraulis & Birmingham, 1964) . The alternative precursor for 18-OH-DOC, 18-hydroxyprogesterone, is also a ready exogenous substrate (Ward & Birmingham, 1962) , but its endogenous presence remains to be established.
Steroid effects on aerobic glycolysis The marked glycolytic response evoked by corticosterone, DOC and 11 ß-hydroxy¬ progesterone confirms previous findings from this laboratory ). The 18-oxygenated compounds were either ineffective or inhibitory when added by themselves. The addition of 18-OH-DOC in combination with DOC, 11 ß-hydroxyprogesterone, or cor¬ ticosterone resulted in a highly significant deficit from an additive response, suggesting the displacement by 18-OH-DOC of the active steroids from some glycolytically relevant receptor site. The early experiments from this laboratory indicated that the glycolytic effect of steroids is proportional to the amount of corticosterone accumulated in the tissue as is their inhibitory effect on protein synthesis (Clayman, Tsang & Johnstone, 1970 (Birmingham, Oliver, Bartova, Frei & Levy, 1979; Beauwens, Crabbé & Birmingham, 1980 (Bell, Brooker & Harding, 1970) , for which AMP and ADP have been shown to be positive effectors (Passonneau & Lowry, 1962; Underwood & Newsholme, 1965; Weidemann, Hems & Krebs, 1969; Hickman & Weidemann, 1973) . Since the nucleosides also caused a slight but significant stimulation of glycolysis, they might have contributed to the glycolytic effects of AMP and GMP to the extent to which these compounds are hydrolysed by the adrenal gland. At a concentration of 10 mmol/1, AMP was only half as effective as cyclic AMP. Cyclic AMP therefore exerted a specific glycolytic effect not attributable to its breakdown to AMP. This could be a direct one such as the activation of a rate-limiting glycolytic enzyme (Passonneau & Lowry, 1962) or an effect on glucose transport, since exogenous glucose is required for a maximal glycolytic response to cyclic AMP , or it could be steroid-mediated.
The manner by which steroids affect aerobic glycolysis is open to debate. Nuclear interaction and enzyme induction are unlikely to account for the in-vitro effects because they occur without delay. Since the glycolytic response to steroids also requires the presence of exogenous glucose, enhancement of glucose transport as well as activation of glycolytic enzymes are possible modes of action. Interaction with an allosteric receptor system could be direct or indirect, such as through reduction of ATP/ADPAMP ratios resulting from steroid metabolism requiring energy-linked NADPH synthesis (Cammer & Estabrook, 1967) or from an inhibition of the NADH oxidase system (Yielding & Tomkins, 1959) .
Functional role of aerobic glycolysis The functional role of aerobic lactic-acid production associated with steroidogenic glands and the stimulation of glycolysis in response to their trophic hormones remains to be established. Since in mouse (but not rat) adrenal glands the steroidogenic response to ACTH
